Cancer remains a leading cause of death worldwide, partly owing to late detection which
entails limited and often ineffective therapeutic options. Most cancers lack validated …

The new generation of cancer early detection tests holds remarkable promise for
revolutionizing and changing the paradigm of cancer early detection. Dozens of cancer early …

Simple Summary Detection of breast cancer in the early stages is associated with higher
cure rates and better survival, and also requires fewer intensive treatments. Current breast …

Close interactions between cancer cells and cancer-associated fibroblasts (CAF) have
repeatedly been reported to support tumor progression. Yet, targeting CAFs has so far failed …

Here, we describe a blood test for the detection of glial malignancies (GLI‐M) based on the
identification of circulating glial cells (CGCs). The test is highly specific for GLI‐M and can …

Breast cancer is an individually unique, multi-faceted and chameleonic disease, an eternal
challenge for the new era of high-integrated precision diagnostic and personalized …

Circulating tumor cells (CTCs) are known to be prognostic for metastatic relapse and are
detected in patients as solitary cells or cell clusters. Circulating tumor cell clusters (CTC …

Circulating tumor cells (CTCs) carry reliable clinical information for the diagnosis and
treatment of cancer that is a malignant disease with a high mortality rate. However, the …

Background The low specificity of serum PSA resulting in the inability to effectively
differentiate prostate cancer from benign prostate conditions is a persistent clinical …

Circulating tumor cells (CTCs) are regarded as harbingers of metastases. Their ability to
predict response to therapy, relapse, and resistance to treatment has proposed their value …